Lintopride

This classification denotes a serotonin antagonist and antiemetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C2R0GEU722. European Medicines Agency schedules Lintopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08526MIG. Lintopride generally arises in the molecular formula C14H19CLN4O2. The term LINTOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, no, 3 1992, list 32.) LINTOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lintopride under HS 29332990 and SITC 51573. As of Q4 2014, LINTOPRIDE remains the US FDA Preferred Term for this commodity. Lintopride bears US NLM identifiers UMLS ID C0378649 and NCI Concept Code C66018. SMILES: CLC1CC(C(=O)NCC2=NCCN2CC)C(OC)CC1N.